User:Synaptophysin/MRC-5: Difference between revisions
←Created page with '{{Userspace draft|source=ArticleWizard|date={{Subst:CURRENTMONTHNAME}} {{Subst:CURRENTYEAR}}}} {{Subst:Nul|<==do not change this line it will set the date automa...' |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Userspace draft|source=ArticleWizard|date=March 2014}} |
{{Userspace draft|source=ArticleWizard|date=March 2014}} |
||
'''MRC-5''' is a diploid human cell culture line composed of fibroblasts derived from lung tissue developed in 1965 in the United Kingdom |
'''MRC-5''' is a diploid human cell culture line composed of fibroblasts derived from lung tissue, developed in 1965 in the United Kingdom |
||
MRC-5 (Medical Research Council cell strain 5) was developed in the United Kingdom, in 1966 by J.P. Jacobs and colleagues. MRC-5 was derived from lung tissue, taken from a 14-week male fetus |
MRC-5 (Medical Research Council cell strain 5) was developed in the United Kingdom, in 1966 by J.P. Jacobs and colleagues. MRC-5 was derived from lung tissue, taken from a 14-week male fetus |
||
Revision as of 14:04, 25 March 2014
 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
MRC-5 is a diploid human cell culture line composed of fibroblasts derived from lung tissue, developed in 1965 in the United Kingdom
MRC-5 (Medical Research Council cell strain 5) was developed in the United Kingdom, in 1966 by J.P. Jacobs and colleagues. MRC-5 was derived from lung tissue, taken from a 14-week male fetus
References
http://www.nature.com/nature/journal/v227/n5254/abs/227168a0.html http://who.int/biologicals/areas/vaccines/WHO_reference_cell_banks/en/
External links
http://www.historyofvaccines.org/content/articles/human-cell-strains-vaccine-development